Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$92.83 -0.58 (-0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported Interest & Investment Income of $3.22 million for Q2 2026, down 0.7% from $3.24 million a year earlier and down 9.4% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rhythm Pharmaceuticals' Interest & Investment Income came in at $15.19 million, up 5.1% year-over-year; for FY2025, it came in at $15.29 million, up 4.0% from FY2024.

  • Interest & Investment Income has increased for four consecutive years, with a five-year compound annual growth rate of 42.8% (FY2020 to FY2025).
  • By year, Interest & Investment Income came in at $14.71 million in FY2024 (+5.5%), $13.95 million in FY2023 (+246.1%), $4.03 million in FY2022 (+801.3%) and $447,000 in FY2021 (-82.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q1 2024.
  • Year over year, Interest & Investment Income gained in four of the last eight quarters, with growth averaging 3.4%.
  • The high point for year-over-year Interest & Investment Income in five years was Q3 2022 (growth of 566.7%); the low point was Q3 2021 (a decline of 70.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.55 million (Q1 2026), $4.09 million (Q4 2025) and $4.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rhythm Pharmaceuticals 6.39 Bn 5.26 Bn 62.32 Mn 3.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.22 Mn
Mar 31, 2026 3.55 Mn
Dec 31, 2025 4.09 Mn
Sep 30, 2025 4.33 Mn
Jun 30, 2025 3.24 Mn
Mar 31, 2025 3.64 Mn
Dec 31, 2024 3.52 Mn
Sep 30, 2024 4.05 Mn
Jun 30, 2024 4.10 Mn
Mar 31, 2024 3.05 Mn
Dec 31, 2023 3.82 Mn
Sep 30, 2023 3.47 Mn
Jun 30, 2023 3.22 Mn
Mar 31, 2023 3.44 Mn
Dec 31, 2022 3.04 Mn
Sep 30, 2022 920,000.00
Jun 30, 2022 274,000.00
Mar 31, 2022 160,000.00
Dec 31, 2021 134,000.00
Sep 30, 2021 138,000.00
API Access

Rhythm Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RYTM&period=max&api_key=YOUR_API_KEY